Cape Ann Savings Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$912K Buy
760
+68
+10% +$69.5K 0.43% 51
2026
Q1
$636K Buy
692
+23
+3% +$23.3K 0.32% 61
2025
Q4
$719K Buy
669
+92
+16% +$88K 0.37% 56
2025
Q3
$440K Buy
+577
New +$429K 0.24% 70
2024
Q1
Sell
-345
Closed -$223K 86
2023
Q4
$223K Buy
+345
New +$201K 0.15% 80

Other funds holding LLY

Cape Ann Savings Bank's LLY Position: Q2 2026 in Review

Cape Ann Savings Bank increased its Eli Lilly (LLY) stake by 9.8% in Q2 2026, buying an estimated $69.5K and bringing the position to 760 shares worth $912K. The position accounts for 0.43% of the portfolio, ranked #51.

Cape Ann Savings Bank first reported a position in LLY in Q4 2023 and has held it in 5 quarters since. 2,861 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cape Ann Savings Bank held 760 shares of Eli Lilly worth $912K as of Q2 2026.
  • Cape Ann Savings Bank bought 68 Eli Lilly shares in Q2 2026, an estimated $69.5K.
  • Eli Lilly made up 0.43% of Cape Ann Savings Bank's portfolio in Q2 2026, its #51 holding.
  • Cape Ann Savings Bank first reported a position in Eli Lilly in Q4 2023 and has held it in 5 quarters since.
  • 2,861 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cape Ann Savings Bank's 13F filing for Q2 2026, filed 4 Aug 2026.